U.S. markets open in 8 hours 57 minutes

Paratek Pharmaceuticals, Inc. (PRTK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.01-0.11 (-1.35%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
46,924
46,924
16,544
17,117
12,616
Cost of Revenue
8,651
8,651
3,484
-
-
Gross Profit
38,273
38,273
13,060
-
-
Operating Expense
113,777
113,777
128,689
121,166
97,037
Operating Income
-75,504
-75,504
-115,629
-104,049
-84,421
Net Non Operating Interest Income Expense
-18,725
-18,725
-12,829
-7,725
-3,702
Other Income Expense
-2,312
-2,312
-31
-80
-193
Pretax Income
-96,541
-96,541
-128,489
-111,854
-88,316
Tax Provision
0
0
301
502
753
Net Income Common Stockholders
-96,541
-96,541
-128,790
-112,356
-89,069
Diluted NI Available to Com Stockholders
-96,541
-96,541
-128,790
-112,356
-89,069
Basic EPS
-
-
-3.93
-3.57
-3.32
Diluted EPS
-
-
-3.93
-3.57
-3.32
Basic Average Shares
-
-
32,792
31,513
26,827
Diluted Average Shares
-
-
32,792
31,513
26,827
Total Operating Income as Reported
-75,504
-75,504
-115,629
-104,085
-84,580
Total Expenses
122,428
122,428
132,173
121,166
97,037
Net Income from Continuing & Discontinued Operation
-96,541
-96,541
-128,790
-112,356
-89,069
Normalized Income
-94,173
-94,173
-128,790
-112,330
-88,974
Interest Income
1,515
1,515
3,574
3,260
1,377
Interest Expense
20,240
20,240
16,403
10,985
5,079
Net Interest Income
-18,725
-18,725
-12,829
-7,725
-3,702
EBIT
-76,301
-76,301
-112,086
-100,869
-83,237
EBITDA
-75,723
-
-
-
-
Reconciled Cost of Revenue
8,651
8,651
3,484
-
-
Reconciled Depreciation
578
578
-1,292
-1,067
1,268
Net Income from Continuing Operation Net Minority Interest
-96,541
-96,541
-128,790
-112,356
-89,069
Total Unusual Items Excluding Goodwill
-2,368
-2,368
0
-36
-159
Total Unusual Items
-2,368
-2,368
0
-36
-159
Normalized EBITDA
-73,355
-73,355
-112,086
-100,833
-81,810
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-9.72
-63.6